On May 13, 2020 Molecular Templates, Inc. (Nasdaq: MTEM, "Molecular Templates" or "MTEM"), a clinical-stage biopharmaceutical company focused on the discovery and development of the company’s proprietary engineered toxin bodies (ETBs), which are differentiated, targeted, biologic therapeutics for cancer and other serious diseases, reported that management will participate in the Bank of America Securities Virtual Healthcare Conference and the UBS Virtual Healthcare Conference (Press release, Molecular Templates, MAY 13, 2020, View Source [SID1234557908]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Bank of America Securities Virtual Healthcare Conference
Date: May 14

UBS Virtual Healthcare Conference
Date: May 18
Presentation Time: 9:10am Eastern Time
Webcast: Click here for webcast